BE.CN - Beleave Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.1000
0.0000 (0.00%)
As of 9:31AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.1000
Open0.1000
Bid0.1000 x 0
Ask0.1000 x 0
Day's Range0.1000 - 0.1000
52 Week Range0.0700 - 0.4100
Volume432,396
Avg. Volume1,643,400
Market Cap47.113M
Beta (3Y Monthly)3.91
PE Ratio (TTM)N/A
EPS (TTM)-0.0860
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.80
  • PR Newswire16 days ago

    Beleave Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization

    TORONTO, April 8, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary Beleave Kannabis Corp has commenced sales of cannabis oil products at its licensed facility in Hamilton, Ontario. Beleave has completed its first wholesale transfer of two bulk lots of cannabis oil to another standard processor license holder, as well as having begun cannabis oil product sales to medicinal patients through its online store https://shop.beleave.com. The Company received authorization from Health Canada to sell cannabis oil products in January 2019.

  • Market Exclusive16 days ago

    Cannabis Stock News Daily Roundup April 8

    Inner Spirit Holdings Ltd. (CSE: ISH) announced that Tilray (NASDAQ: TLRY) has increased its total investment in Inner Spirit to $6 million as part of an investment and strategic partnership agreement announced in December 2018. Terra Tech Corp. (OTCQX: TRTC) has secured a permit from the State of Nevada to manufacture cannabis for the adult-use market at its 15,000 sq. […]The post Cannabis Stock News Daily Roundup April 8 appeared first on Market Exclusive.

  • PR Newswire19 days ago

    Beleave Granted Building Permit for Upcoming London Expansion

    TORONTO, April 5, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has received a Building Permit and moved forward in the Health Canada Licensing process for its facility in London, Ontario. In September 2018, Beleave purchased the existing 250,000 sq. ft. greenhouse facility and has since been developing the property. This includes the installation of 10 megawatts of electrical capacity fully serviced by London Hydro, HVAC, equipment, and site engineering exceeding industry standards.

  • PR Newswire2 months ago

    Beleave Announces Board and Management Refresh

    James (Jim) Wasserstrom: A native of New York, Jim has extensive international experience and expertise in governance, compliance and internal control. Jim spent the early part of his career in various corporate capacities, including as a global partnerships executive for American Express Travel Related Services.  In 2002, Jim led the United Nations operation overseeing Kosovo's public utilities representing $4 billion in assets transforming many into modern and profitable businesses.  From 2009-2014, Mr. Wasserstrom led the US effort to combat corruption for the United States Government in Afghanistan, engaging extensively with the military, and international organizations and governments.

  • PR Newswire2 months ago

    Medi-Green Invites the Community to Grand Opening of its New Clinic in London, Ontario

    TORONTO, Feb. 12, 2019 /PRNewswire/ - Medi-Green, a wholly-owned subsidiary of Beleave (BE.CN) (BLEVF) ("Beleave" or the "Company") is excited to invite the community to the grand opening event of its new clinic in London, Ontario this Friday, February 15, 2019. "We are very excited to expand our Medi-Green family into the London region and continue to provide a comforting and encouraging environment for patients seeking medical cannabis as a form of treatment," said Ashleigh Koeslag, Operations Manager. During the event, staff from Medi-Green will be present to answer questions and share information about cannabis and the clinic's services with attendees.

  • CNW Group3 months ago

    Beleave Awarded ISO 9001:2015 Certification as Part of Ongoing Commitment to Improve Efficiency

    TORONTO , Jan. 31, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corporation, has obtained ISO 9001:2015 Certification for the research, development, and production of cannabis products for medicinal and recreational purposes at its Hamilton, Ontario facility. ISO 9001 is a quality management system standard developed by the International Organization for Standardization, an association of governmental and nongovernmental organizations from many countries. ISO 9001:2015 is the most up-to-date standard of its kind and contains key updates, including an emphasis on risk-based thinking to enhance the application of the process approach, improved applicability for services, and increased leadership requirements.

  • PR Newswire3 months ago

    Beleave Provides an Update on the BCSC's Temporary Order

    TORONTO, Jan. 17, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its participation and cooperation regarding the ongoing investigation by the British Colombia Securities Commission ("BCSC"). As previously announced, Beleave was named as a respondent in a temporary order dated November 26, 2018 (the "Temporary Order") issued by the Executive Director of the BCSC in connection with distributions to certain individuals connected to the "BridgeMark Group". The Executive Director of the BCSC sought an extension of the Temporary Order (the "Extension Request") pending the conclusion of the BCSC's investigation into the Respondents' reliance on the Consultant Exemption.

  • CNW Group3 months ago

    Beleave Announces Executive Management Developments and Provides Activity Updates

    TORONTO , Jan. 16, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that Bill Panagiotakopoulos , current COO at Beleave, has been appointed by the Board of Directors to act as the Executive Chairman to further strengthen Beleave's governance and oversight controls. As one of the Company's founding members in 2011, Bill was an early mover in Canada's cannabis sector. Since then, Bill has been significantly involved in the successful navigation of the regulatory framework to obtain cannabis production and sales licenses.

  • Market Exclusive3 months ago

    Cannabis Stock News Daily Roundup January 16

    Cannabis News Cannabis producer FoliuMed has completed the construction of its first greenhouses on a 16-hectare grow site near Bogota, Colombia. In an area spanning 20 soccer fields, FoliuMed will produce over 70 tons of medicinal hemp and cannabis plants in 150 greenhouses. The plants will be processed into oils and sold as pharma-grade ingredients […] The post Cannabis Stock News Daily Roundup January 16 appeared first on Market Exclusive.

  • PR Newswire3 months ago

    Beleave Receives Health Canada Authorization to Sell Cannabis Oils

    TORONTO, Jan. 15, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is excited to announce its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations. "This license is pivotal to us meeting our goals in 2019, while driving product innovation and augmenting our research and development initiatives," said Roger Ferreira, Ph.D., Beleave's Chief Science Officer.

  • CNW Group4 months ago

    Beleave Provides Update and Clarification on GMP Certification Process

    TORONTO , Dec. 17, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update and clarification on the Company's GMP certification process. As part of the process, Global Compliance Inc. has inspected and assessed the Company's processes for the production of medical and recreational cannabis and determined that the facility meets all requirements for certification. Beleave is seeking GMP certification so the Company can export medical cannabis to its German partner, Canymed GmbH, and expects to be audited by the German GMP certification authority early next year.

  • PR Newswire4 months ago

    CORRECTION - Beleave Announces GMP Certification and Operational Updates

    Please note that the below is a corrected version of the news release previously disseminated December 13th at 5pm. Beleave Inc. has advised that changes were made to the third and fourth paragraphs. TORONTO, Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use.

  • CNW Group4 months ago

    Beleave Announces GMP Certification and Operational Updates

    TORONTO , Dec. 13, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use. This certification solidifies the practices the Company has been perfecting in relation to product development and it demonstrates our commitment to food safety and hygiene.

  • CNW Group5 months ago

    Beleave Announces Second Quarter of 2018 Results

    TORONTO , Nov. 29, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces today the release of its Interim Condensed Consolidated Financial Statements for the second quarter ended September 30, 2018 , together with its Management, Discussion and Analysis ("MD&A"). All values in this news release and the Company's financial disclosures are in Canadian dollars unless otherwise stated. The Company had revenues of $315,617 that didn't include recreational sales that began in October, however it was an improvement over last quarter's revenues of $208,617 .